Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enlicitide bioavailability in healthy adults under fed and fasted conditions
NCT07776665Phase 1Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1 trial of enlicitide in hypercholesterolemia (5 arms), sponsored by Merck & Co. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time Zero to Infinity at 168 hours and Maximum Observed Plasma Concentration at 168 hours. Started Aug 2026; status: active, not recruiting.
02
Drugs
enlicitide
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07776665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776665.